HEPHAISTOS-Pharma

Hephaïstos - Hephaistos Pharma

Orsay, France · Founded 2018 · $7.6M raised

Headquarters
Orsay
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$7.6M
Last Round
$5.2M Extension RoundMay 2024
Rounds
2

About

HEPHAISTOS-Pharma is a biopharmaceutical company developing 3rd generation TLR4 agonist small-molecule innate immune boosters designed to convert myeloid-rich, immunosuppressive tumors into immunotherapy-responsive tumors. The companys lead drug candidate, HEPHA440, has demonstrated compelling anti-tumor activity across a broad spectrum of preclinical cancer models both as a monotherapy and in combination with checkpoint inhibitors, with clinical trials planned for 2027. Founded in 2018 and headquartered in Orsay, France, HEPHAISTOS-Pharma has secured 10.3M in funding and is backed by investors including Elaia.

Summary

HEPHAISTOS-Pharma is a Biotech company based in Orsay, France, founded in 2018. It has raised $7.6M in total across 2 rounds, most recently a $5.2M Extension Round round in May 2024. Investors include XISTA Science Ventures, Elaia and Noshaq.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundMay 2024
$5.2M

Sign up to see all 2 rounds

Seed through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HEPHAISTOS-Pharma on Indexed.vc
<a href="https://indexed.vc/companies/hephaistos-pharma"><img src="https://indexed.vc/api/badge/company/hephaistos-pharma" alt="HEPHAISTOS-Pharma on Indexed.vc" width="260" height="76" /></a>